The authorization for the Gene-RADAR Zika Virus Test is designed to cut the amount of time it takes for a diagnosis of the Zika Virus by analyzing blood samples with nanotechnology.
Theranos confirmed the withdrawal to the Wall Street Journal, but didn't say anything about the FDA inspection. Instead, company officials tried once again to put on a happy face.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The vendor sent a specific notice via the EHR to 94 clinicians at 24 different athenahealth clients, serving 1,800 at-risk patients in the affected area of Miami.
The preview of a prototype device with no timeline offered for regulatory approval gives one pause as to how the company will have the means to commercialize the miniLab, considering how much credibility Theranos has lost.
The states aren’t addressing the challenge low-income women face in getting birth control. And, for those who do get pregnant, there are still major barriers to accessing potentially helpful prenatal care.
Also, The World Health Organization has posted a final version of its proposed biologics naming policy, and new research suggests that the financial burden that cancer care puts on many people contributes to lower survival rates.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.